New Developments in Prokinetic Therapy for Gastric Motility Disorders
Prokinetic agents amplify and coordinate the gastrointestinal muscular contractions to facilitate the transit of intra-luminal content. Following the institution of dietary recommendations, prokinetics are the first medications whose goal is to improve gastric emptying and relieve symptoms of gastro...
Main Authors: | Michael Camilleri, Jessica Atieh |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.711500/full |
Similar Items
-
Reprogramming of gastric motility with "pulse therapy" (metoclopramide and erythromycin) in severe gastroparesis
by: Shamik Shah, et al.
Published: (2013-01-01) -
Chinese herbal medicine for functional dyspepsia: a network meta-analysis of prokinetic-controlled randomised trials
by: Leonard Ho, et al.
Published: (2021-12-01) -
Microsponge based drug delivery system for augmented gastroparesis therapy: Formulation development and evaluation
by: Riyaz Ali M. Osmani, et al.
Published: (2015-10-01) -
Management of Dyspepsia and Gastroparesis in Patients with Diabetes. A Clinical Point of View in the Year 2021
by: Silvia Bonetto, et al.
Published: (2021-03-01) -
Efficacy comparison between oral erythromycin versus domperidone for the treatment of feeding intolerance in preterm neonatesWhat's known on this subjectWhat this study adds
by: Pattarapan Sukwuttichai, et al.
Published: (2021-09-01)